# Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected Anesthetics

> **NCT00198549** · PHASE4 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 40 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Vitrase (ovine hyaluronidase) Lyophilized

## Key facts

- **NCT ID:** NCT00198549
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2005-01
- **Final completion:** 2005-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2013-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00198549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00198549, "Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected Anesthetics". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00198549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*